Press Releases
Executive Q&A Samsung Biologics
As part of our continued commitment to technology innovation, Samsung Biologics leverages the latest CDO platforms like S-AfuCHO™, S-OptiCharge™, and S-Tensify™ to enhance therapeutic efficacy and meet evolving industry needs. Get insights from this interview on how we accelerate development, achieve the highest quality, and flexibly meet clients' goals.
As part of our continued commitment to technology innovation, Samsung Biologics leverages the latest CDO platforms like S-AfuCHO™, S-OptiCharge™, and S-Tensify™ to enhance therapeutic efficacy and meet evolving industry needs. Get insights from this interview on how we accelerate development, achieve the highest quality, and flexibly meet clients' goals.